tryptophanrich
antigen
malari
parasit
interact
host
molecul
play
import
role
parasit
surviv
merozoit
express
plasmodium
vivax
tryptophanrich
antigen
bind
human
erythrocyt
facilit
parasit
growth
heterlolog
plasmodium
falciparum
cultur
system
recent
identifi
band
human
erythrocyt
one
receptor
although
receptorligand
bind
mechan
remain
unknown
present
studi
use
synthet
mutat
peptid
show
multipl
amino
acid
residu
amino
acid
domain
kwvqwkndkir
posit
interact
three
differ
ectodomain
band
receptor
human
erythrocyt
find
may
help
design
new
therapeut
approach
malaria
sequenc
amino
acid
posit
aim
investig
bind
mechan
parasit
ligand
host
erythrocyt
receptor
band
also
determin
whether
tryptophan
residu
domain
play
role
erythrocyt
bind
result
obtain
show
multipl
site
amino
acid
long
peptid
domain
includ
two
tryptophan
residu
interact
differenti
band
ectodomain
replac
amino
acid
alanin
affect
erythrocyt
bind
activ
peptid
heparin
blood
collect
healthi
individu
accord
institut
ethic
guidelin
written
consent
obtain
individu
prior
blood
collect
ethic
committe
india
institut
medic
scienc
new
delhi
approv
studi
via
approv
number
purifi
histidinetag
bacteri
thioredoxin
band
fragment
avail
laboratori
ophenyldiamin
rpmi
hypoxanthin
penicillinstreptomycin
polyllysin
monoclon
antibodi
sigmaaldrich
st
loui
mo
usa
chip
coupl
reagent
ge
healthcar
uppsala
sweden
fb
lipofectamin
alexa
flour
conjug
goat
antimous
antirabbit
igg
invitrogen
life
technolog
carlsbad
ca
usa
horseradish
peroxidas
conjug
antimous
igg
secondari
antibodi
pierc
biotechnolog
inc
rockford
il
usa
obtain
commerci
mutat
peptid
three
consecut
amino
acid
residu
replac
alanin
residu
mutat
peptid
singl
amino
acid
residu
replac
alanin
residu
synthes
commerci
thermo
fischer
scientif
gmbh
ulm
germani
without
six
histidin
residu
attach
ctermin
end
assay
perform
describ
previous
approxim
million
human
erythrocyt
fix
well
microtit
plate
block
bsa
incub
lm
mutat
wildtyp
peptid
h
room
temperatur
recombin
desulfovibrio
desulfurican
thioredoxin
use
neg
control
plate
wash
pb
contain
tween
incub
mous
monoclon
antihi
antibodi
serotech
raleigh
nc
usa
dilut
follow
horseradish
peroxidas
conjug
antimous
igg
secondari
antibodi
develop
ophenyldiamin
substrat
assay
perform
describ
previous
briefli
cell
line
american
type
cultur
collect
manassa
va
usa
transfect
plasmid
use
cation
lipid
lipofectamin
roset
erythrocyt
hematocrit
ad
cell
express
incub
h
humidifi
co
incub
h
incub
cell
wash
four
time
incomplet
rpmi
medium
ph
number
rosett
five
erythrocyt
bound
transfect
cell
score
field
magnif
normal
transfect
effici
competit
assay
erythrocyt
hematocrit
preincub
peptid
lm
incomplet
rpmi
ph
h
ad
transfect
cell
number
rosett
score
describ
assay
purifi
band
perform
describ
previous
briefli
well
elisa
plate
coat
nm
band
protein
block
skim
milk
incub
lm
histidinetag
peptid
wildtyp
mutat
form
h
room
temperatur
plate
develop
mous
monoclon
antihi
antibodi
describ
bind
band
fragment
synthet
peptid
well
elisa
plate
separ
coat
lm
synthet
peptid
block
skim
milk
pb
plate
incub
lm
trxtag
band
fragment
develop
mous
monoclon
antitrxtag
antibodi
describ
kinet
bind
peptid
band
fragment
determin
surfac
plasmon
reson
spr
base
biosensor
biacor
biacor
ab
uppsala
sweden
experi
perform
mm
hepe
ph
contain
mm
nacl
mm
edta
surfact
addit
block
nonspecif
adsorpt
analyt
sensor
chip
experi
ligand
coupl
either
serv
control
flow
cell
experi
perform
either
immobil
band
fragment
onto
sensor
chip
use
aminecoupl
chemistri
accord
protocol
describ
previous
bind
measur
avoid
mass
transport
effect
bind
measur
dissoci
monitor
addit
sensor
chip
regener
puls
mm
glycin
ph
sensogram
obtain
control
flow
cell
subtract
data
flow
cell
immobil
ligand
spr
data
analyz
use
biaevalu
version
ge
healthcar
global
fit
appar
equilibrium
dissoci
constant
k
calcul
k
k
k
k
dissoci
rate
constant
k
associ
rate
constant
erythrocyt
bind
activ
domain
resid
amino
acid
region
recent
report
amino
acid
long
domain
bind
human
erythrocyt
well
purifi
band
protein
narrow
erythrocyt
bind
activ
domain
mutat
peptid
synthes
three
consecut
amino
acid
residu
systemat
replac
three
alanin
residu
use
erythrocyt
bind
assay
cellular
elisa
result
tabl
show
replac
first
three
amino
acid
peptid
three
alanin
residu
result
abolit
erythrocyt
bind
activ
restor
first
three
amino
acid
residu
wildtyp
mutat
next
three
amino
acid
residu
alanin
restor
bind
activ
abolit
erythrocyt
bind
activ
continu
amino
acid
residu
fig
tabl
howev
replac
three
amino
acid
residu
posit
thereaft
result
restor
erythrocyt
bind
activ
result
therefor
elimin
possibl
last
six
amino
acid
involv
erythrocyt
bind
similar
result
obtain
mutat
peptid
allow
compet
express
surfac
cell
erythrocyt
bind
roset
assay
fig
result
obtain
two
differ
assay
indic
first
amino
acid
residu
amino
acid
residu
peptid
domain
import
erythrocyt
bind
activ
map
critic
amino
acid
residu
amino
acid
domain
involv
erythrocyt
bind
synthes
wildtyp
mutat
peptid
singl
amino
acid
residu
replac
alanin
stepwis
manner
use
erythrocyt
bind
assay
cellular
elisa
result
show
erythrocyt
bind
activ
reduc
certain
amino
acid
residu
within
amino
acid
region
replac
alanin
tabl
analog
bind
experi
cellular
elisa
perform
bind
inhibit
experi
bind
erythrocyt
roset
cell
express
compet
wildtyp
peptid
mutat
form
mutat
peptid
show
trend
similar
observ
cellular
elisa
fig
amino
acid
residu
peptid
domain
erythrocyt
bind
activ
markedli
affect
reduct
five
amino
acid
maximum
effect
erythrocyt
bind
activ
observ
asparagin
residu
replac
alanin
replac
first
last
amino
acid
amino
acid
peptid
alanin
minim
effect
erythrocyt
bind
activ
multipl
site
amino
acid
region
also
interact
purifi
erythrocyt
band
protein
use
mutat
peptid
describ
solidphas
bind
assay
purifi
band
protein
instead
erythrocyt
last
six
amino
acid
residu
amino
acid
long
domain
involv
bind
band
tabl
similarli
multipl
amino
acid
residu
amino
acid
domain
also
interact
purifi
band
protein
tabl
pattern
similar
erythrocyt
bind
activ
mutat
peptid
replac
asparagin
alanin
peptid
avii
also
show
maximum
reduct
bind
activ
mutat
peptid
respect
purifi
band
protein
compar
wildtyp
peptid
band
bind
activ
mutat
peptid
aiii
axi
valin
arginin
replac
alanin
respect
also
maxim
affect
compar
wildtyp
peptid
result
confirm
band
erythrocyt
surfac
interact
multipl
site
amino
acid
domain
differenti
recognit
band
ectodomain
multipl
site
amino
acid
region
result
report
show
bind
band
host
erythrocyt
via
multipl
site
amino
acid
peptid
domain
previous
shown
peptid
interact
three
differ
ectodomain
band
fragment
perform
interact
three
band
fragment
mutat
peptid
solid
phaseelisa
well
spr
aim
identifi
critic
amino
acid
residu
involv
interact
band
ectodomain
observ
major
amino
acid
amino
acid
domain
interact
specif
individu
loop
band
assay
ie
solid
phase
elisa
fig
spr
tabl
bind
mutat
peptid
maxim
affect
amino
acid
posit
peptid
aiii
peptid
aiv
peptid
avii
domain
replac
alanin
fig
mutat
peptid
avi
peptid
aix
peptid
axi
also
affect
interact
similar
result
obtain
spr
analysi
mutat
peptid
aiii
aiv
avii
show
approxim
reduct
bind
affin
toward
wherea
avi
aix
axi
show
approxim
reduct
bind
affin
compar
wildtyp
tabl
case
interact
mutat
peptid
ai
affect
compar
amino
acid
mutat
posit
peptid
aiii
peptid
axi
solid
phase
elisa
fig
howev
spr
data
show
almost
similar
bind
affin
three
peptid
reduc
approxim
compar
wildtyp
peptid
tabl
bind
mutat
peptid
maxim
affect
amino
acid
posit
peptid
aii
peptid
av
peptid
avii
peptid
axi
solid
phase
elisa
fig
similar
result
obtain
spr
mutat
peptid
show
approxim
reduct
bind
affin
compar
wildtyp
tabl
mutat
peptid
ax
also
slightli
affect
bind
assay
result
indic
ectodomain
band
recogn
specif
amino
acid
locat
certain
posit
except
bind
two
loop
interact
three
ectodomain
band
onetoon
interact
indic
spr
data
also
correl
well
erythrocyt
bind
activ
mutat
peptid
interf
hostparasit
molecular
interact
requir
parasit
surviv
growth
lead
develop
antimalari
therapeut
therefor
parasit
molecul
involv
hostcel
invas
hold
great
import
human
erythrocyt
band
interact
number
p
falciparum
protein
play
import
role
host
cell
invas
recent
shown
p
vivax
tryptophanrich
antigen
involv
hostparasit
interact
band
present
human
erythrocyt
also
act
one
receptor
also
defin
amino
acid
long
peptid
domain
sequenc
kwvqwkndkirswlssew
amino
acid
posit
interact
three
differ
ectodomain
band
defin
domain
amino
acid
residu
peptid
alanin
scan
show
last
six
amino
acid
peptid
essenti
bind
tabl
bind
activ
wildtyp
almost
compar
howev
chang
triplet
caus
drastic
reduct
bind
activ
mutat
peptid
compar
bind
activ
display
mutant
peptid
singl
amino
acid
chang
triplet
appear
result
addit
effect
furthermor
show
five
amino
acid
residu
pvtrag
locat
within
tabl
bind
activ
truncat
mutat
peptid
band
fragment
surfac
plasmon
reson
sequenc
number
peptid
name
wild
ae
ae
ae
ai
ae
ae
ae
aii
ae
ae
ae
aiii
ae
ae
ae
aiv
ae
ae
ae
av
ae
ae
ae
avi
ae
ae
ae
avii
ae
ae
ae
aviii
ae
ae
ae
domain
critic
bind
erythrocyt
interact
differ
three
ectodomain
band
fig
tabl
asparagin
residu
amino
acid
domain
critic
bind
amino
acid
residu
mutat
residu
peptid
avii
result
loss
maximum
erythrocyt
bind
activ
fig
tabl
probabl
reason
could
attribut
stronger
interact
observ
two
differ
ectodomain
loop
loop
band
protein
spr
tabl
although
peptid
aiii
mutat
also
interact
two
loop
loop
loop
erythrocyt
bind
activ
affect
lesser
extent
peptid
avii
mutat
differ
erythrocyt
bind
activ
could
attribut
weaker
interact
peptid
aiii
loop
loop
band
compar
mutat
peptid
avii
interact
strongli
loop
loop
loop
band
tabl
glutamin
residu
amino
acid
peptid
domain
interact
loop
band
mutat
caus
drastic
reduct
k
valu
spr
although
affect
erythrocyt
bind
activ
proportion
mutat
peptid
interact
singl
loop
also
show
minimum
effect
erythrocyt
bind
activ
except
aii
also
interact
singl
loop
loop
affect
erythrocyt
bind
activ
mutat
peptid
bind
singl
loop
inde
effect
mutat
erythrocyt
bind
activ
mutat
peptid
aii
case
mutat
peptid
avi
although
latter
interact
three
loop
mutant
peptid
mention
five
amino
acid
replac
alanin
show
reduc
affin
least
one
band
loop
thu
account
correspond
reduc
red
blood
cell
rbc
bind
mutant
peptid
ai
reduc
affin
loop
spr
unabl
affect
rbc
bind
tryptophan
residu
sever
protein
play
import
role
proteinprotein
interact
bind
interfac
proteinprotein
interact
probabl
tryptophan
residu
maxim
compar
amino
acid
number
studi
tryptophan
residu
play
import
role
biochem
biolog
function
plasmodium
phist
domain
phista
famili
member
contain
two
posit
conserv
tryptophan
residu
one
play
import
role
interact
host
erythrocyt
cytoskelet
protein
band
member
class
cytokin
receptor
superfamili
tryptophan
rich
motif
wxxwwsxw
involv
variou
function
includ
ligand
bind
bind
region
also
contain
wxxw
motif
could
provid
anchor
role
bind
band
hostparasit
interact
conserv
tryptophan
rich
motif
involv
membran
infus
hiv
viru
sar
viru
ebola
viru
present
context
know
whether
tryptophan
residu
involv
function
although
may
specul
help
parasit
fuse
erythrocyt
membran
invas
host
cell
merozoit
presenc
duffi
independ
pathway
invas
effect
vaccin
p
vivax
requir
multipl
epitop
subunit
vaccin
regard
amino
acid
region
could
use
part
subunit
vaccin
natur
cours
p
vivax
infect
patient
elicit
good
humor
cellular
immun
respons
natur
antibodi
inhibit
erythrocyt
bind
activ
protein
well
peptid
furthermor
sequenc
domain
highli
conserv
parasit
popul
seen
facilit
parasit
growth
heterolog
p
falciparum
cultur
system
find
need
confirm
p
vivax
robust
cultur
system
becom
avail
parasit
ad
protein
p
falciparum
cultur
lead
parasit
growth
inhibit
could
result
bind
band
human
erythrocyt
receptor
merozoit
protein
parasit
consid
band
common
receptor
p
falciparum
p
vivax
merozoit
protein
amino
acid
peptid
similar
molecul
could
inhibit
parasit
growth
develop
therapeut
agent
small
organ
molecul
peptid
bind
proteinprotein
interfac
subsequ
inhibit
hostparasit
interact
develop
therapeut
plasmodium
conclus
amino
acid
residu
stretch
bind
erythrocyt
band
via
multipl
amino
acid
critic
amino
acid
present
interfac
hot
spot
bind
would
prove
help
design
therapeut
malaria
chetan
chitni
thank
dr
pawan
malhotra
make
biacor
facil
avail
shalini
narang
prepar
manuscript
prior
submiss
also
acknowledg
use
facil
biotechnolog
inform
system
bti
biotechnolog
depart
funder
role
studi
design
data
collect
analysi
decis
publish
prepar
manuscript
yd
design
studi
wrote
paper
msa
perform
solid
phase
assay
band
fragment
well
roset
assay
spr
wrote
paper
rkt
perform
erythrocyt
bind
assay
sr
perform
spr
